Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alok Sharma

Interventional Cardiology Minneapolis, MN Medical Doctor

NPI 1750542049 CMS profile 1384021

1 Veterans Dr # 111-C, Minneapolis, MN 55417

Open in the dashboard

General payments

$21,405

167 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$160,503 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Alok Sharma of Minneapolis, MN is reported in the CMS Open Payments database as having received $21,405 across 167 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $160,503 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 76th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $636 8
2024 General $1,747 19
2023 General $485 8
2022 General $1,050 17
2021 General $6,626 22
2020 General $1,474 8
2019 General $9,387 85

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alok Sharma
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Alok Sharma were reported at $636. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Alok Sharma Interventional Cardiology median Middle half National median
2019 $9,387 $1,097 $329–$3,048 $163
2020 $1,474 $473 $161–$1,480 $114
2021 $6,626 $677 $233–$1,827 $132
2022 $1,050 $978 $333–$2,724 $149
2023 $485 $1,136 $382–$2,986 $160
2024 $1,747 $1,181 $395–$3,326 $164
2025 $636 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cardiovascular Systems Inc. $6,288 12 payments
  2. Boston Scientific Corporation $6,202 55 payments
  3. Edwards Lifesciences Corporation $3,046 31 payments
  4. Medtronic Vascular, Inc. $2,853 26 payments
  5. Abbott Laboratories $1,760 29 payments
  6. Abiomed $346 5 payments
  7. Medtronic, Inc. $342 3 payments
  8. Gentuity, LLC $265 2 payments
  9. Biotronik Inc. $145 2 payments
  10. Teleflex LLC $122 1 payment
  11. Other $36 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $7,300 3 payments
  2. Food and Beverage $7,298 138 payments
  3. Travel and Lodging $5,907 25 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $900 1 payment
Products named General payments · program years 2019–2025
  1. Diamondback Peripheral $3,927 4 payments
  2. General Therapies Therapies $2,884 3 payments
  3. CoreValve Evolut $2,530 23 payments
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,659 13 payments
  5. Coronary Orbital Atherectomy System $1,277 5 payments
  6. GENERAL THERAPIES General Therapies $1,109 10 payments
  7. LOTUS EDGE $1,059 7 payments
  8. Diamondback Coronary $984 2 payments
  9. Edwards SAPIEN 3 Transcatheter Heart Valve $357 3 payments
  10. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $348 6 payments
  11. Other $5,143 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record